Synthesis and Properties of Carbohydrate-Based BODIPY-Functionalised Fluorescent Macrocycles
作者:Yanhua Yu、Nicolas Bogliotti、Jie Tang、Juan Xie
DOI:10.1002/ejoc.201300953
日期:2013.12
Carbohydrate-based 23- to 28-membered BODIPY-containing macrocycles have been efficiently synthesised from alkyne-functionalised BODIPY acid, C-glucosyl azido amine, and amino acids by employing CuAAC for the macrocyclisation step. BF(OMe) and B(OMe)2 derivatives have also been obtained by treating macrocycle 1 with BCl3 in CH2Cl2 followed by treatment with MeOH. These compounds exhibited similar excellent
[EN] BIOACTIVE COMPOUNDS FOR TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉS BIOACTIFS POUR LE TRAITEMENT DU CANCER ET DES MALADIES NEURODÉGÉNÉRATIVES
申请人:PONIARD PHARMACEUTICALS INC
公开号:WO2009139834A1
公开(公告)日:2009-11-19
The invention provides bioactive compounds for the treatment of various malconditions such as cancer and neurodegenerative diseases including Alzheimer's disease. The chemical compounds as disclosed herein are found to show bioactivity in bioassays related to these conditions. Pharmaceutical compositions, combinations and methods of synthesis are provided, as are methods of using the compound, compositions and combinations in the treatment of the diseases.
The present invention relates to compounds of formula (I) and compositions containing said compounds acting as PARP (Poly (ADP- ribose) polymerase) inhibitors. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine, in particular for the treatment of cell proliferative disorders, such as cancer.